Across TCGA pan-cancer cohorts, CATSPER4 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CATSPER4 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in sarcoma (SARC), where higher CATSPER4 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CATSPER4 expression acts as an unfavorable survival marker.

SARC and PRAD are the cancer types where CATSPER4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	DFS	Median	All	0.094	0.632	<.001	6	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CATSPER4 tumor-vs-normal RNA expression · all CATSPER4 data types